REGENERON PHARMACEUTICALS, INC.

A biotech firm inventing, developing, and commercializing medicines for serious diseases.

REGN | US

Overview

Corporate Details

ISIN(s):: US75886F1075
LEI:
Country:: United States of America
Address:: 777 OLD SAW MILL RIVER ROAD, 10591 TARRYTOWN
Website:: https://www.regeneron.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Regeneron Pharmaceuticals, Inc. is a leading biotechnology company that invents, develops, manufactures, and commercializes medicines for people with serious diseases. Founded in 1988, the company leverages its scientific and technological capabilities to produce a portfolio of treatments and a pipeline of product candidates. Its research and development efforts span multiple therapeutic areas, including ophthalmology, oncology, cardiovascular and metabolic diseases, and inflammatory conditions. Regeneron focuses on turning cutting-edge science into transformative medicines, with active programs in areas such as genetic medicines (including CRISPR), cancer-fighting immunotherapies, and treatments for obesity.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all REGENERON PHARMACEUTICALS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for REGENERON PHARMACEUTICALS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for REGENERON PHARMACEUTICALS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Future Medicine Co., Ltd. Clinical-stage biopharma developing novel synthetic drugs for inflammation, fibrosis, and oncology.	South Korea	341170
G2GBIO, Inc. Develops long-acting injectable therapies for chronic diseases and cancer.	South Korea	456160
Gabather AB Developing novel GABAA receptor drugs for neuropsychiatric disorders.	Sweden	GABA
Galapagos NV Biotech firm developing novel CAR-T cell therapies for oncology via a rapid delivery platform.	Belgium	GLPG
Galderma Group AG A pure-play dermatology company with aesthetics, skincare, and therapeutic solutions.	Switzerland	GALD
GALECTIN THERAPEUTICS INC Developing galectin-3 inhibitors for MASH cirrhosis, fibrosis, and cancer.	United States of America	GALT
Galecto, Inc. Develops novel small molecule drugs targeting cancer and severe fibrotic diseases.	United States of America	GLTO
Galmed Pharmaceuticals Ltd. Develops oral therapeutics for liver, metabolic, and inflammatory diseases like NASH.	United States of America	GLMD
GC CELL CORPORATION Biotech firm offering cell/gene therapy CDMO services and developing immune cell cancer therapies.	South Korea	144510
Gelteq Ltd Ingestible gel platform for enhanced oral delivery of drugs & nutrients for human & animal health.	United States of America	GELS